³Ô¹ÏÍøÕ¾

Latest Doherty Institute News | Page 2

Genomics has helped identify a new strep A strain in Australia – and what has made it dangerous
TGA confirms the performance of Australian approved Rapid Antigen Tests with COVID-19 Variants
Twice as many Victorians may have had COVID-19 in January 2022 than reported, new analysis reveals
Breakthrough testing standard developed for Covid RATs
Optimise Study deemed success in directly informing Victoria’s COVID-19 response
Breaking ground: Moderna’s big build begins
Paxlovid is Australia’s first-line COVID antiviral but Lagevrio also prevents severe disease in over-70s
Your handy guide to latest COVID subvariants
Dodging death: Surprise discovery redirects efforts for treatment of liver disease
COVID Nasal Spray Treatment Clinical Trials To Begin
5 virus families that could cause next pandemic, according to experts
Leading Pandemic Therapeutics Centre In Melbourne
Burnet recognises stellar service of departing Board members
Outstanding scientists don’t work alone: collaborations in Asia-Pacific region
Victoria’s first mRNA innovation hub backed by state government
Victoria Investing In World-First mRNA Innovation Hub
Burnet research honoured at AIDS 2022
Decade Long Plan For ³Ô¹ÏÍøÕ¾ Grown Medical Research To Thrive
Rapid Antigen Test cancellations not due to failure to detect Covid Omicron variant
By June 2022, almost half of adult Australian population is estimated to have had Covid
³Ô¹ÏÍøÕ¾ antibody study: By June, almost half of Aussies had recently had Covid
Combating drug-resistant bacteria
Mapping ‘energy fingerprints’ of lung cancer leads to fundamental treatment rethink
³Ô¹ÏÍøÕ¾ antibody study confirms Covid cases higher than reported
How Covid created dramatic changes in ‘winter virus’
Volunteers receive first dose in clinical trial of Melbourne-made Covid vaccines
More natural air ventilation systems for NSW schools
New Fellowship To Continue Fight Against Infectious Diseases
Why Sentinel Cells are so Important
Recruitment commences for Phase 1 clinical trial of two Melbourne-made Covid vaccines
Doherty Institute secures landmark agreement with Moderna to expedite vaccine research for infectious diseases
Vaccine-induced T cells provide long-lasting immune response to Covid: study
How many Australians have had Covid?
Blood Donors Sought For New Covid Research Biobank
Covid clinical trials disproportionately run out of high-income countries research shows
Cannibal immune cells could offer new treatment path
Protecting remote communities in Northern Territory from Covid 2 February
Researchers discover way to disarm potentially deadly Listeria bacteria
Researchers discover new approach to breaking bacterial antibiotic resistance and rescue frontline drug treatments
Researchers discover new approach to breaking bacterial antibiotic resistance and rescue frontline drug treatments
Spleen function discovery could lead to better treatments for infectious diseases
T cells fit to tackle Omicron, suggests new study
Nasal spray to fight Covid heads to clinical trial
Burnet and Doherty scientists develop highly accurate point-of-care neutralising antibodies test for Covid
Protecting remote communities in Northern Territory from Covid 21 December
Jab Gab – where scientists discuss Covid vaccines, with unlikely help of comedians
Minister updated on research into Omicron variant, AIID Foundation Partners Agreement signed
Infectious Disease Institute Partners Set New Foundation